Sergei Gryaznov
2021
In 2021, Sergei Gryaznov earned a total compensation of $576.5K as Chief Scientific Officer at MAIA Biotechnology.
Compensation breakdown
| Bonus | $115,500 |
|---|---|
| Option Awards | $183,980 |
| Salary | $238,542 |
| Other | $38,485 |
| Total | $576,507 |
Gryaznov received $238.5K in salary, accounting for 41% of the total pay in 2021.
Gryaznov also received $115.5K in bonus, $184K in option awards and $38.5K in other compensation.
Rankings
In 2021, Sergei Gryaznov's compensation ranked 10,410th out of 12,415 executives tracked by ExecPay. In other words, Gryaznov earned more than 16.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,410 out of 12,415 | 16th |
Division Manufacturing | 4,611 out of 5,508 | 16th |
Major group Chemicals And Allied Products | 2,065 out of 2,378 | 13th |
Industry group Drugs | 1,832 out of 2,099 | 13th |
Industry Pharmaceutical Preparations | 1,359 out of 1,549 | 12th |
Source: SEC filing on April 19, 2023.
Gryaznov's colleagues
We found three more compensation records of executives who worked with Sergei Gryaznov at MAIA Biotechnology in 2021.